title: Serum Levels of Thioredoxin Are Associated with Stroke Risk, Severity, and Lesion Volumes.
abstract: Oxidative stress increases serum thioredoxin (TRX), a redox-regulating protein with antioxidant activity recognized as an oxidative stress marker. The aim of this study was to assess the clinical significance of serum TRX levels in Chinese patients with acute ischemic stroke (AIS). From January 1, 2012, to December 31, 2013, all patients with first-ever acute ischemic stroke were recruited to participate in the study. Serum levels of TRX were assayed with solid-phase sandwich enzyme-linked immunosorbent assay (ELISA), and the severity of stroke was evaluated with the National Institutes of Health Stroke Scale (NIHSS) score on admission. The results indicated that the median serum TRX levels were significantly (P < 0.0001) higher in stroke patients as compared to normal cases [15.03 ng/mL (interquartile range (IQR), 10.21-32.42) and 8.95 ng/mL (6.79-11.05), respectively]. We found the serum TRX reflected the disease severity of AIS. There was a significant positive association between serum TRX levels and NIHSS scores (r = 0.476, P < 0.0001). After adjusting for all other possible covariates, TRX remained as an independent marker of AIS with an adjusted OR of 1.245 (95 % confidence interval (CI), 1.164-1.352; P < 0.0001). Based on the receiver operating characteristic (ROC) curve, the optimal cutoff value of serum TRX levels as an indicator for auxiliary diagnosis of AIS was projected to be 11.0 ng/mL, which yielded a sensitivity of 80.3 % and a specificity of 73.7 %, with the area under the curve at 0.807 (95 % CI, 0.766-0.847). Further, in our study, we found that an increased risk of AIS was associated with serum TRX levels ≥11.0 ng/mL (adjusted OR 6.99; 95 % CI, 2.87-12.87) after adjusting for possible confounders. Our study demonstrated that serum TRX levels at admission were associated with stroke severity and lesion volumes. Elevated levels could be considered as a novel, independent diagnosis marker of AIS in a Chinese sample.
authors.affiliation: Department of Neurology, Laiwu People's Hospital, No. 1, Xuehudajie, Changshao North Road, Laiwu, 271100, Shandong Province, China.
authors.forename: Meng-Hai
authors.initials: MH
authors.lastname: Wu
authors.affiliation: Department of Neurology, Laiwu People's Hospital, No. 1, Xuehudajie, Changshao North Road, Laiwu, 271100, Shandong Province, China.
authors.forename: Fang-Yu
authors.initials: FY
authors.lastname: Song
authors.affiliation: Department of Neurology, Laiwu People's Hospital, No. 1, Xuehudajie, Changshao North Road, Laiwu, 271100, Shandong Province, China.
authors.forename: Li-Ping
authors.initials: LP
authors.lastname: Wei
authors.affiliation: Special Procurement Ward, Laiwu People's Hospital, No. 1, Xuehudajie, Changshao North Road, Laiwu, 271100, Shandong Province, China.
authors.forename: Zhao-Yun
authors.initials: ZY
authors.lastname: Meng
authors.affiliation: Department of Cardiology, Laiwu People's Hospital, No. 1, Xuehudajie, Changshao North Road, Laiwu, 271100, Shandong Province, China. luxxyy796@163.com.
authors.forename: Zhi-Qiang
authors.initials: ZQ
authors.lastname: Zhang
authors.affiliation: Department of Neurology, Laiwu People's Hospital, No. 1, Xuehudajie, Changshao North Road, Laiwu, 271100, Shandong Province, China. qiqde634@126.com.
authors.forename: Qin-De
authors.initials: QD
authors.lastname: Qi
mesh_terms: D000368:Aged; D015415:Biomarkers / Q000097:blood; D002545:Brain Ischemia / Q000097:blood* / Q000175:diagnosis*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D012720:Severity of Illness Index; D020521:Stroke / Q000097:blood* / Q000175:diagnosis*; D013879:Thioredoxins / Q000097:blood*
chemical_list: D015415:Biomarkers; D013879:Thioredoxins
keywords: Acute ischemic stroke; Chinese; Oxidative stress; Risk; Thioredoxin